लोड हो रहा है...
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
BACKGROUND: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and increase weight loss efficacy in combination with...
में बचाया:
| में प्रकाशित: | Mol Metab |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085567/ https://ncbi.nlm.nih.gov/pubmed/33166741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101109 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|